Vorinostat Withdrawn Phase N/A Trials for Triple-Negative Breast Cancer (TNBC) / Stage IIIA Breast Cancer / Stage II Breast Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01695057Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer